Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$7.1 - $12.82 $19,880 - $35,896
-2,800 Reduced 2.22%
123,100 $874,000
Q3 2021

Nov 15, 2021

SELL
$7.64 - $12.49 $3.88 Million - $6.35 Million
-508,200 Reduced 80.15%
125,900 $1.38 Million
Q2 2021

Sep 13, 2021

BUY
$8.68 - $27.49 $5.5 Million - $17.4 Million
634,100 New
634,100 $5.5 Million

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.